Payment overview · 2025
General Payments
$91.49
4 reported records · 3 companies
Healthcare provider profile · identity verified
Henry Igdal, M.D.
Allopathic & Osteopathic Physicians|General Practice · EASLEY, SC · NPI 1346259280
Verified facts
What the public records show
CMS Open Payments records show Henry Igdal, M.D. received $91.49 in general payments during 2025 across 4 reported records.
Viatris Specialty LLC accounted for 42.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza, Nuplazid.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Nuplazid by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Ingrezza by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Viatris Specialty LLC | Unresolved — no canonical attribution shown | $39.08 | 42.7% | 2 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $28.19 | 30.8% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $24.22 | 26.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $91.49 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| YUPELRI Normalized: yupelri |
Drug | Viatris Specialty LLC | $39.08 | 2 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $28.19 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $24.22 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 19 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 29 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1239 | 236 |
| Levothyroxine Sodium | Levothyroxine Sodium | 997 | 119 |
| Gabapentin | Gabapentin | 874 | 148 |
| Eliquis | Apixaban | 763 | 96 |
| Amlodipine Besylate | Amlodipine Besylate | 736 | 137 |
| Furosemide | Furosemide | 666 | 108 |
| Mirtazapine | Mirtazapine | 509 | 117 |
| Tamsulosin Hcl | Tamsulosin Hcl | 457 | 89 |
| Metoprolol Tartrate | Metoprolol Tartrate | 424 | 94 |
| Lisinopril | Lisinopril | 401 | 78 |
| Carvedilol | Carvedilol | 366 | 77 |
| Trazodone Hcl | Trazodone Hcl | 320 | 83 |
| Pravastatin Sodium | Pravastatin Sodium | 294 | 64 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 284 | 62 |
| Levetiracetam | Levetiracetam | 273 | 55 |
| Montelukast Sodium | Montelukast Sodium | 271 | 44 |
| Potassium Chloride | Potassium Chloride | 267 | 69 |
| Donepezil Hcl | Donepezil Hcl | 265 | 44 |
| Metformin Hcl | Metformin Hcl | 260 | 57 |
| Sertraline Hcl | Sertraline Hcl | 257 | 64 |
| Meloxicam | Meloxicam | 254 | 52 |
| Clopidogrel | Clopidogrel Bisulfate | 253 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 248 | 56 |
| Pantoprazole Sodium | Pantoprazole Sodium | 217 | 51 |
| Omeprazole | Omeprazole | 203 | 58 |
| Divalproex Sodium | Divalproex Sodium | 189 | 51 |
| Losartan Potassium | Losartan Potassium | 184 | 41 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 176 | 24 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 176 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 162 | 39 |
| Allopurinol | Allopurinol | 148 | 25 |
| Memantine Hcl | Memantine Hcl | 137 | 35 |
| Midodrine Hcl | Midodrine Hcl | 134 | 31 |
| Tizanidine Hcl | Tizanidine Hcl | 129 | 21 |
| Latanoprost | Latanoprost | 128 | 28 |
| Buspirone Hcl | Buspirone Hcl | 126 | 34 |
| Baclofen | Baclofen | 120 | 24 |
| Ondansetron Hcl | Ondansetron Hcl | 120 | 65 |
| Quetiapine Fumarate | Quetiapine Fumarate | 110 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 109 | 25 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 105 | 18 |
| Finasteride | Finasteride | 105 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 102 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 102 | 20 |
| Prednisone | Prednisone | 99 | 49 |
| Hydralazine Hcl | Hydralazine Hcl | 98 | 27 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 98 | 36 |
| Jardiance | Empagliflozin | 98 | 14 |
| Xarelto | Rivaroxaban | 97 | 17 |
| Levofloxacin | Levofloxacin | 95 | 47 |
| Ropinirole Hcl | Ropinirole Hcl | 94 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 90 | 55 |
| Myrbetriq | Mirabegron | 90 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 86 | 38 |
| Lamotrigine | Lamotrigine | 86 | 14 |
| Cephalexin | Cephalexin | 84 | 38 |
| Risperidone | Risperidone | 79 | 21 |
| Torsemide | Torsemide | 79 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 78 | 22 |
| Humalog Kwikpen U-100 | Insulin Lispro | 78 | 18 |
| Metoclopramide Hcl | Metoclopramide Hcl | 78 | 19 |
| Famotidine | Famotidine | 75 | 20 |
| Spironolactone | Spironolactone | 71 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 69 | 42 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | 16 |
| Trulicity | Dulaglutide | 67 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 64 | 44 |
| Azithromycin | Azithromycin | 62 | 40 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 61 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 61 | 13 |
| Ceftriaxone | Ceftriaxone Sodium | 60 | 44 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 59 | 44 |
| Topiramate | Topiramate | 58 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 56 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 55 | 32 |
| Bupropion Xl | Bupropion Hcl | 55 | suppressed |
| Budesonide | Budesonide | 53 | 15 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 53 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 50 | 29 |
| Simvastatin | Simvastatin | 50 | 12 |
| Lokelma | Sodium Zirconium Cyclosilicate | 49 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 48 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 47 | 31 |
| Oxybutynin Chloride | Oxybutynin Chloride | 46 | suppressed |
| Mounjaro | Tirzepatide | 44 | suppressed |
| Ezetimibe | Ezetimibe | 43 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 42 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 42 | 17 |
| Insulin Aspart Flexpen | Insulin Aspart | 42 | suppressed |
| Sucralfate | Sucralfate | 42 | 12 |
| Breyna | Budesonide/Formoterol Fumarate | 41 | suppressed |
| Januvia | Sitagliptin Phosphate | 41 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 40 | 12 |
| Clonidine Hcl | Clonidine Hcl | 39 | 13 |
| Oxcarbazepine | Oxcarbazepine | 39 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 38 | 11 |
| Glipizide | Glipizide | 38 | suppressed |
| Linzess | Linaclotide | 38 | suppressed |
| Atenolol | Atenolol | 37 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 37 | suppressed |
| Bumetanide | Bumetanide | 36 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 35 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 34 | suppressed |
| Fluconazole | Fluconazole | 34 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 34 | 15 |
| Lidocaine | Lidocaine | 33 | 11 |
| Lidocaine Hcl | Lidocaine Hcl | 33 | 26 |
| Sumatriptan Succinate | Sumatriptan Succinate | 33 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 32 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 32 | suppressed |
| Tradjenta | Linagliptin | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 31 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 30 | suppressed |
| Mirabegron Er | Mirabegron | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 29 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 28 | suppressed |
| Calcium Acetate | Calcium Acetate | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 27 | suppressed |
| Aripiprazole | Aripiprazole | 26 | suppressed |
| Colchicine | Colchicine | 26 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 26 | suppressed |
| Ketoconazole | Ketoconazole | 26 | 14 |
| Digoxin | Digoxin | 25 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 25 | suppressed |
| Amantadine | Amantadine Hcl | 24 | suppressed |
| Cefdinir | Cefdinir | 24 | 18 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 24 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 23 | 19 |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Methimazole | Methimazole | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Ranolazine Er | Ranolazine | 22 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Olanzapine | Olanzapine | 21 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Klor-Con 10 | Potassium Chloride | 20 | suppressed |
| Scopolamine | Scopolamine | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 20 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Ertapenem | Ertapenem Sodium | 19 | suppressed |
| Ingrezza | Valbenazine Tosylate | 19 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 19 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 19 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 11 |
| Glipizide Er | Glipizide | 18 | suppressed |
| Lactulose | Lactulose | 18 | 13 |
| Lovastatin | Lovastatin | 18 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | 12 |
| Acetazolamide | Acetazolamide | 17 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 17 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Anastrozole | Anastrozole | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Lubiprostone | Lubiprostone | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | 12 |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Klayesta | Nystatin | 14 | 12 |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Phenytoin | Phenytoin | 14 | suppressed |
| Zonisamide | Zonisamide | 14 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 13 | 11 |
| Teflaro | Ceftaroline Fosamil Acetate | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Famciclovir | Famciclovir | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 12 | 11 |
| Nystatin | Nystatin | 12 | suppressed |
| Repatha Syringe | Evolocumab | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $91.49 · 4 records | Viatris Specialty LLC | INGREZZA, NUPLAZID, YUPELRI | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error